Education
About Us
Working with TipRanks
Follow Us
Cambridge Cognition Holdings Plc (GB:COG)
LSE:COG
COG Stock Chart & Stats
28.00p
-0.58p(-1.49%)
At close: 4:00 PM EST
28.00p
-0.58p(-1.49%)
Day’s Range― - ―
52-Week Range23.90p - 47.00p
Previous CloseN/A
Volume352.00
Average Volume (3M)32.00K
Market Cap
£18.39M
Enterprise Value19.45M
Total Cash (Recent Filing)£428.00K
Total Debt (Recent Filing)£1.48M
Price to Earnings (P/E)―
Beta0.63
Next Earnings
May 06, 2026EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding46,629,700
10 Day Avg. Volume24,264
30 Day Avg. Volume32,004
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)4.31
Price to Sales (P/S)1.40
P/FCF Ratio-4.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£56.00Price Target Upside100.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross Margins From Software ProductsAn 81.1% gross margin indicates a software-centric, scalable offering with low incremental costs per additional user. This margin profile supports reinvestment in R&D, clinical validation and commercialisation, providing durable margin leverage as revenue recovers or grows over the medium term.
Improved Equity And Balance Sheet StabilityEquity improving to £3.36M signals stronger solvency versus prior years and reduces immediate insolvency risk. A positive equity base and 25.8% equity ratio give the company more flexibility to raise capital or invest, making its financial position more resilient over the next several quarters.
Established Market Position In Cognitive AssessmentOwning the CANTAB product suite and long-standing relationships with academic, clinical and pharma customers creates a structural competitive advantage. Institutional licensing, recurring subscriptions and clinical trial partnerships support multi-year demand and high switching costs for customers.
Bears Say
Material Revenue DeclineA 2024 revenue drop represents weakening top-line traction and reduces the company's ability to absorb fixed costs. Continued revenue shrinkage undermines operating leverage, risks eroding customer momentum and makes return to profitable scale more challenging absent clear growth drivers.
Negative Operating And Free Cash FlowSustained negative operating and free cash flow indicate the business is consuming cash to fund operations. This reduces financial flexibility, may necessitate external financing or dilution, and constrains investment in sales, product development and regulatory work over the next 2-6 months.
Ongoing Operating LossesNegative EBIT and net margins show operations are not yet profitable after underlying costs. Persistent losses force reliance on capital markets or partners for runway, limit strategic options, and increase risk if revenue recovery is slow or funding conditions tighten.
Cambridge Cognition Holdings News
COG FAQ
What was Cambridge Cognition Holdings Plc’s price range in the past 12 months?
Cambridge Cognition Holdings Plc lowest share price was 23.90p and its highest was 47.00p in the past 12 months.
What is Cambridge Cognition Holdings Plc’s market cap?
Cambridge Cognition Holdings Plc’s market cap is £18.39M.
When is Cambridge Cognition Holdings Plc’s upcoming earnings report date?
Cambridge Cognition Holdings Plc’s upcoming earnings report date is May 06, 2026 which is in 78 days.
How were Cambridge Cognition Holdings Plc’s earnings last quarter?
Cambridge Cognition Holdings Plc released its earnings results on Aug 28, 2025. The company reported -0.024p earnings per share for the quarter, missing the consensus estimate of -0.014p by -0.01p.
Is Cambridge Cognition Holdings Plc overvalued?
According to Wall Street analysts Cambridge Cognition Holdings Plc’s price is currently Undervalued.
Does Cambridge Cognition Holdings Plc pay dividends?
Cambridge Cognition Holdings Plc does not currently pay dividends.
What is Cambridge Cognition Holdings Plc’s EPS estimate?
Cambridge Cognition Holdings Plc’s EPS estimate is >-0.01.
How many shares outstanding does Cambridge Cognition Holdings Plc have?
Cambridge Cognition Holdings Plc has 46,629,700 shares outstanding.
What happened to Cambridge Cognition Holdings Plc’s price movement after its last earnings report?
Cambridge Cognition Holdings Plc reported an EPS of -0.024p in its last earnings report, missing expectations of -0.014p. Following the earnings report the stock price went up 25%.
Which hedge fund is a major shareholder of Cambridge Cognition Holdings Plc?
Currently, no hedge funds are holding shares in GB:COG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cambridge Cognition Holdings Plc
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases IIV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; CANTAB Insight, a medical device that helps to determine an individual's cognitive health; and NeuroVocalix for an automated administration and scoring of well-validated verbal cognitive assessments?on a secure platform. In addition, the company offers a range of expert consultancy and operational management services to optimize clinical trials and cognitive research, which include neuroscience and technical consultancy, study design, data analysis, study and data management, and reports and interpretation. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.
COG Stock 12 Month Forecast
Average Price Target
56.00p
▲(100.00% Upside)
Technical Analysis
Options Prices
Currently, No data available
---